A Phase I Study of DS-3201B in Subjects With Acute Myelogenous Leukemia (AML) Or Acute Lymphocytic Leukemia (ALL)
Clinical Trial Grant
Awarded By
Daiichi Sankyo Inc
Start Date
September 19, 2018
End Date
February 24, 2024
Awarded By
Daiichi Sankyo Inc
Start Date
September 19, 2018
End Date
February 24, 2024